Masatoshi Watanabe
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism 13
- Carcinogens and Genotoxicity Assessment 10
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 16
- Oncology top 2%
- Cancer-related Molecular Pathways 14
-
- Genetic factors in colorectal cancer 18
-
- Prostate Cancer Treatment and Research 46
- Prostate Cancer Diagnosis and Treatment 13
-
- Urologic and reproductive health conditions 9
- Co-authors
- Taizo ShiraishiRyuichi YataniHitoshi NakagamaHaruo ItôYoshifumi HirokawaHiroyoshi SuzukiTsuyoshi NakayamaTakashi Sügimura
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Masatoshi Watanabe
240 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 1.4k
- Molecular Biology 2.9k
- Oncology 1.1k
- Pathology and Forensic Medicine 694
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Masatoshi Watanabe
This map shows the geographic impact of Masatoshi Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Watanabe more than expected).
Fields of papers citing papers by Masatoshi Watanabe
This network shows the impact of papers produced by Masatoshi Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Watanabe. The network helps show where Masatoshi Watanabe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masatoshi Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 0 | |
| 7 | 2020 | 6 | |
| 8 | 2018 | 18 | |
| 9 | 2015 | 2 | |
| 10 | 2008 | 151 | |
| 11 | 2004 | 10 | |
| 12 | 1997 | 0 | |
| 13 | 1995 | 41 | |
| 14 | 1988 | 1 | |
| 15 | BACTERIOLOGICAL AND CLINICAL STUDIES ON CS-807 | 1988 | 1 |
| 16 | 1987 | 1 | |
| 17 | [Antiemetic efficacy of high-dose hydrocortisone in patients receiving cisplatin therapy]. | 1986 | 1 |
| 18 | Bacteriological and clinical studies on at-2266 | 1984 | 1 |
| 19 | 1983 | 2 | |
| 20 | 1977 | 1 |
About Masatoshi Watanabe
Masatoshi Watanabe is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 262 papers that have together received 6.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (46 papers), Genetic factors in colorectal cancer (18 papers), Epigenetics and DNA Methylation (16 papers), Cancer-related Molecular Pathways (14 papers), Cancer, Lipids, and Metabolism (13 papers), Prostate Cancer Diagnosis and Treatment (13 papers), Carcinogens and Genotoxicity Assessment (10 papers) and Urologic and reproductive health conditions (9 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (2.9k citations) and Oncology (1.1k citations). Masatoshi Watanabe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Taizo Shiraishi, Ryuichi Yatani, Hitoshi Nakagama, Haruo Itô, Yoshifumi Hirokawa, Hiroyoshi Suzuki, Tsuyoshi Nakayama, Takashi Sügimura, Daisuke Kurioka and R Yatani. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.